BioCanRx funding for proof-of-concept preclinical and early phase studies testing oncology biotherapeutics (next intake: July 29)
BioCanRx’s next intake deadline for letters of intent is July 29, 2016 by 11:59 p.m. ET.
BioCanRx is accepting letters of intent for the following four research programs:
- Clinical Trials Program
- Enabling Studies Program
- Catalyst Program
- Clinical, Social and Economic Impact Program
For research program details and more information about the open call application process, please visit our website at www.biocanrx.com/application-process/. This funding opportunity is available to any investigator in a Canadian institution that is eligible to receive funding from CIHR, NSERC and SSHRC.
BioCanRx was announced as a Network of Centres of Excellence on December 15, 2014, with a total of $60 million in funding and commitments from the NCE Program and more than 25 partners. Their goals are to:
- To advance four new cancer biotherapies into Canadian-led clinical trials by 2020
- To build a strong and vibrant cancer biotherapeutics community in Canada